Phase II open-label randomized multi-centre study of neoadjuvant olaparib in patients (pts) with platinum sensitive (PS) relapsed high grade serous ovarian cancer (OC): The NEO trial.
- Authors:
- Y Kanjanapan, S Lheureux, T May, MK Wilson, M Bernardini, PA Shaw, I Vergote, JD Brenton, DM Provencher, LA McNeish, P Ghatage, JA Ledermann, N Colombo, C Gourley, J Weberpals, J Ramsahai, N Ricker, S Accardi, L Wang, AM Oza
- Journal:
- JOURNAL OF CLINICAL ONCOLOGY
- Citation info:
- Vol. 35
- Publication date:
- 1st Aug 2017
- Full text
- DOI